Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2697 |
|
Actual shortage: | 241 (9%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2447 (91%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
26 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-DILTIAZEM XC | 180MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-10-12 | 2023-12-07 | 206904 |
TEVA-PIROXICAM | 20MG | CAPSULE | Resolved | 2023-10-19 | 2024-02-15 | 207435 |
TEVA-AMPICILLIN | 500MG | CAPSULE | Resolved | 2023-10-19 | 2023-11-09 | 207494 |
TEVA-FUROSEMIDE | 20MG | TABLET | Resolved | 2023-10-19 | 2024-01-11 | 207497 |
TEVA-CEPHALEXIN 250 | 250MG | POWDER FOR SUSPENSION | Resolved | 2023-10-19 | 2024-02-15 | 207500 |
TEVA-DOMPERIDONE | 10MG | TABLET | Resolved | 2023-10-19 | 2023-11-30 | 207506 |
TEVA-NAPROXEN SODIUM DS | 550MG | TABLET | Resolved | 2023-10-19 | 2023-11-09 | 207509 |
TEVA-IPRATROPIUM STERINEBS | 250MCG | SOLUTION | Resolved | 2023-10-19 | 2024-06-13 | 207512 |
TEVA-NITROFURANTOIN | 50MG | CAPSULE | Resolved | 2023-10-19 | 2023-11-30 | 207515 |
TEVA-METFORMIN | 500MG | TABLET | Resolved | 2023-10-19 | 2023-12-07 | 207521 |
TEVA-ALENDRONATE | 70MG | TABLET | Resolved | 2023-10-19 | 2023-12-07 | 207524 |
TEVA-OLANZAPINE | 15MG | TABLET | Resolved | 2023-10-19 | 2023-12-14 | 207527 |
TEVA-TELMISARTAN | 40MG | TABLET | Resolved | 2023-10-19 | 2024-05-03 | 207530 |
EPIRUBICIN FOR INJECTION | 2MG | SOLUTION | Resolved | 2023-10-19 | 2023-11-30 | 207533 |
TEVA-MYCOPHENOLATE | 500MG | TABLET | Resolved | 2023-10-19 | 2024-02-22 | 207536 |
TEVA-MYCOPHENOLATE | 250MG | CAPSULE | Resolved | 2023-10-19 | 2023-12-07 | 207539 |
TEVA-DUTASTERIDE | 0.5MG | CAPSULE | Resolved | 2023-10-19 | 2024-04-11 | 207548 |
TEVA-TADALAFIL | 20MG | TABLET | Resolved | 2023-10-19 | 2024-03-21 | 207551 |
TEVA-SPIRONOLACTONE/HCTZ | 50MG 50MG | TABLET | Resolved | 2023-10-26 | 2023-11-09 | 208251 |
TEVA-BETAHISTINE | 8MG | TABLET | Resolved | 2023-10-26 | 2023-11-23 | 208254 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-ROSUVASTATIN | 40MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157437 |
PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.375G 3G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210191 |
PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.5G 4G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210194 |
CEFAZOLIN FOR INJECTION | 10G | POWDER FOR SOLUTION | Discontinued | 2023-11-27 | 2023-11-27 | 211558 |
TEVA-ECTOSONE | 0.1% | LOTION | Discontinued | 2023-12-05 | 2023-12-05 | 212526 |
TEVA-DICLOFENAC EC | 25MG | TABLET (ENTERIC-COATED) | Discontinued | 2024-01-25 | 2024-01-26 | 217254 |
TEVA-IRBESARTAN | 75MG | TABLET | Discontinued | 2024-04-01 | 2024-04-01 | 224049 |
VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | To be discontinued | 2019-07-05 | 2019-07-05 | 88619 |
ACT CELECOXIB | 100MG | CAPSULE | To be discontinued | 2020-09-03 | 2020-09-03 | 123648 |
ACT CELECOXIB | 200MG | CAPSULE | To be discontinued | 2020-09-03 | 2020-09-03 | 123651 |